Affinity of anti-insulin-like growth factor I receptor antibody binding to the receptor altered by plant lectins

被引:0
作者
Kusada, Yu [1 ]
Fujita-Yamaguchi, Yoko [1 ]
机构
[1] Tokai Univ, Dept Appl Biochem, Hiratsuka, Kanagawa 2591292, Japan
基金
日本学术振兴会;
关键词
Altered affinity; scFv; IGF-IR; lectin; SINGLE-CHAIN ANTIBODIES; WHEAT-GERM-AGGLUTININ; BREAST-CANCER CELLS; MONOCLONAL-ANTIBODIES; COLORECTAL-CANCER; TUMOR-GROWTH; INHIBITION; EXPRESSION;
D O I
10.5582/bst.2011.v5.3.93
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The binding ability of anti-insulin-like growth factor. receptor (IGF-IR) single-chain variable fragments (scFvs) to IGF-IR was measured in the presence of plant lectins. Combinations of concanavalin A (Con A), wheat germ agglutinin (WGA), or peanut agglutinin (PNA) and 1H7 or 3B7 anti-IGF-IR scFv/phage antibodies that were previously produced and characterized were used. WGA inhibited binding of both scFvs proteins to the receptor. PNA slightly enhanced the binding of 1H7 scFv and phage antibody to the receptor. Con A led to enhancement of 3B7 scFv-binding but had no effect in a test of phage antibodies and determination of kinetic parameters. The effect of lectins differed for scFvs and phage antibodies, implying that affinity altered by lectins is dependent upon the molecular structure of the antibodies. Results indicated that animal lectins may affect the affinity of therapeutic antibodies targeting cell membrane receptors in vivo.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 28 条
[1]  
Burtrum D, 2003, CANCER RES, V63, P8912
[2]  
BUXSER SE, 1983, J BIOL CHEM, V258, P3741
[3]   MEASUREMENTS OF THE TRUE AFFINITY CONSTANT IN SOLUTION OF ANTIGEN-ANTIBODY COMPLEXES BY ENZYME-LINKED IMMUNOSORBENT-ASSAY [J].
FRIGUET, B ;
CHAFFOTTE, AF ;
DJAVADIOHANIANCE, L ;
GOLDBERG, ME .
JOURNAL OF IMMUNOLOGICAL METHODS, 1985, 77 (02) :305-319
[4]   A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts [J].
Goetsch, L ;
Gonzalez, A ;
Leger, O ;
Beck, A ;
Pauwels, PJ ;
Haeuw, JF ;
Corvaia, N .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (02) :316-328
[5]  
Haddad Tufia, 2006, Future Oncol, V2, P101, DOI 10.2217/14796694.2.1.101
[6]  
Höpfner M, 2006, WORLD J GASTROENTERO, V12, P5635
[7]   Blocking insulin-like growth factor-I receptor as a strategy for targeting cancer [J].
Hofmann, F ;
García-Echeverría, C .
DRUG DISCOVERY TODAY, 2005, 10 (15) :1041-1047
[8]   Construction and characterization of single-chain antibodies against human insulin-like growth factor-I receptor from hybridomas producing IH7 or 3B7 monoclonal antibody [J].
Kusada, Yu ;
Morizono, Torn ;
Matsumoto-Takasak, Ayano ;
Sakai, Keiko ;
Sato, Shuma ;
Asanuma, Hideki ;
Takayanagi, Atsushi ;
Fujita-Yamaguchi, Yoko .
JOURNAL OF BIOCHEMISTRY, 2008, 143 (01) :9-19
[9]  
Kusada Y, 2007, BIOSCI TRENDS, V1, P128
[10]   Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer [J].
Lee, CT ;
Park, KH ;
Adachi, Y ;
Seol, JY ;
Yoo, CG ;
Kim, YW ;
Han, SK ;
Shim, YS ;
Coffee, K ;
Dikov, MM ;
Carbone, DP .
CANCER GENE THERAPY, 2003, 10 (01) :57-63